Journal of Oncology / 2010 / Article / Tab 1

Case Report

Intrahepatic Sarcomatoid Cholangiocarcinoma

Table 1

Clinicopathological features of previously published patients with sarcomatoid cholangiocarcinoma.

no. of patientsSarcomatoid componentTreatmentSurvival

Kaibori et al. [7]1Pleomorphic and spindle cellsSurgeryPatient died ≤3 months after surgery with recurrence
Sumiyoshi et al. [8]1Spindle cellNonePatient died within 2 months after diagnosis
Sato et al. [2]1Round cell variantNonePatient died within 3 months of diagnosis
Nakajima et al. [5]7Spindle cell (5)Surgery (2)- Patient died ≤3 months after diagnosis (4)
Pleomorphic and spindle cell (2)TAE (2)- Patient died 3–6 months after diagnosis (2)
Chemotherapy* (1)- Patient alive beyond 6 months (1)
None (2)
Aishima et al. [3]7Not availableSurgery (7)5 patients died of disease recurrence. 3 year survival (17.9%)

TAE (Trans arterial chemoembolisation), *details of chemotherapy not available.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.